The pharmacology of leukotrienes (LT) C4 and D4 in isolated airway smooth muscle was investigated. In rat trachea, neither LTC4 or D4 elicited a response. In contrast, LTC4 was a potent contractile agonist in guinea-pig trachea, bronchus and parenchymal lung strip. Similar effects were obtained with LTD4 in trachea and parenchyma. In trachea and bronchus, the concentration-response curve to LTC4 was biphasic: indomethacin converted the biphasic response curve to a simple sigmoidal shape and enhanced the maximum contractile response. The SRS-A antagonist FPL 55712 antagonized the effect of LTD4 in both trachea and parenchyma. As regards LTC4-induced contraction of trachea and bronchus, FPL 55712, depending on concentration, either antagonized, or antagonized and enhanced the maximum contractile response. The enhancement of the maximum contractile response by FPL 55712 was not apparent when indomethacin was present. FPL 55712 failed to antagonize the effect of LTC4 in parenchyma.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0090-6980(81)90101-5DOI Listing

Publication Analysis

Top Keywords

fpl 55712
16
trachea bronchus
12
maximum contractile
12
contractile response
12
isolated airway
8
airway smooth
8
smooth muscle
8
ltd4 trachea
8
trachea parenchyma
8
enhanced maximum
8

Similar Publications

Objective And Design: In the present study, we investigated the relation between the inflammatory mediators such as nitric oxide, prostaglandins, and cysteinyl-leukotrienes with mucin release and the sympathetic system in submandibular glands from rats with experimental periodontitis.

Materials Or Subjects: Submandibular glands from rats with experimental periodontitis.

Treatment: For the first experiment, rats were treated with hydrocortisone sc, 1 mg/kg for 3 days.

View Article and Find Full Text PDF

Leukotrienes, antileukotrienes and asthma.

Mini Rev Med Chem

June 2008

Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Largo F. Vito, 1, 00168 Rome, Italy.

Leukotrienes (LTs), including LTB(4) and cysteinyl-LTs (CysLTs) (LTC(4), LTD(4), and LTE(4)), are potent inflammatory lipid mediators which are derived from 5-lipoxygenase activity. CysLTs, which stimulate CysLT(1) and CysLT(2) receptor subtypes, are functionally involved in the pathophysiology of asthma. Selective CysLT(1) receptor antagonists are effective anti-asthmatic drugs.

View Article and Find Full Text PDF

Leukotriene modifiers: novel therapeutic opportunities in asthma.

Farmaco

March 2002

Centro di Farmacologia Cardiopolmonare Sperimentale, Dip. of Pharmacol. Sciences, School of Pharmacy, Univ. of Milan, Italy.

Article Synopsis
  • Cysteinyl leukotrienes (Cys-LT) are inflammatory compounds linked to asthma, and several drugs like zafirlukast have been developed to target them.
  • Zafirlukast was created through a strategic drug discovery process that modified existing compounds for better selectivity and potency against leukotriene receptors.
  • While leukotriene biosynthesis inhibitors like BAY X-1005 showed promise in clinical trials, they ultimately did not demonstrate consistent effectiveness across all asthma patients, leading to their discontinuation.
View Article and Find Full Text PDF

Leukotrienes (LTs), tachykinins (TKs), and oxygen radicals have been suggested to be important modulating factors for the hyperpnea-induced bronchoconstriction (HIB) of guinea pigs. In this study, we tested the hypothesis that LTs and oxygen radicals modulate HIB by triggering TK release. Eighty-five Hartley guinea pigs were divided into four groups: control, dimethylthiourea (DMTU), FPL 55712, and A63162.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!